Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

67 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Recruiting

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

NCT07222488

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Michael G Oefelein Clinical Trials ( Site 0005) Bakersfield, California, United States
  • Carolina Urologic Research Center ( Site 0006) Myrtle Beach, South Carolina, United States
  • Medizinische Universität Wien ( Site 0021) Vienna, State of Vienna, Austria
  • UZ Gent ( Site 0031) Ghent, Oost-Vlaanderen, Belgium
View all 15 locations
View Trial Details
Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

NCT07218380

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine Irvine, California, United States
View all 286 locations
View Trial Details
Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Bronchial Neoplasms, +52 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 158 locations
View Trial Details
Recruiting

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

NCT07566156

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Samsun Clinic - Ridley-Tree Cancer Center Santa Barbara, California, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View Trial Details
Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

NCT06833073

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +13 more
Locations
  • Michael G Oefelein Clinical Trials ( Site 0138) Bakersfield, California, United States
  • Genesis Research, LLC ( Site 0141) Los Alamitos, California, United States
  • USC Norris Comprehensive Cancer Center ( Site 0123) Los Angeles, California, United States
  • Genesis Healthcare-Torrance ( Site 0140) Torrance, California, United States
View all 89 locations
View Trial Details
Recruiting

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

NCT05614739

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
Locations
  • University of Arizona - Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) - Division of Hematology-Oncology Los Angeles, California, United States
  • University of California - Irvine Orange, California, United States
View all 82 locations
View Trial Details
Recruiting

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

NCT06960577

Conditions
Cisplatin, Doxorubicin, Female Urogenital Diseases, +14 more
Locations
  • Research Site Chermside, Australia
  • Research Site Elizabeth Vale, Australia
  • Research Site Heidelberg, Australia
  • Research Site Hong Kong, Australia
View all 59 locations
View Trial Details

Related conditions